Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.

Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Abstract Text:

    nan-yao leeNan-Yao Lee,hsin-chun leeHsin-Chun Lee,nai-ying koNai-Ying Ko,chia-ming changChia-Ming Chang,hsin-i shihHsin-I Shih,chi-jung wuChi-Jung Wu,wen-chien koWen-Chien Ko,nan-yao leeNan-Yao Lee,hsin-chun leeHsin-Chun Lee,nai-ying koNai-Ying Ko,chia-ming changChia-Ming Chang,hsin-i shihHsin-I Shih,chi-jung wuChi-Jung Wu,wen-chien koWen-Chien Ko,

    OBJECTIVE: To investigate the impact of antimicrobial resistance on clinical and economic outcomes among hospitalized patients with multidrug-resistant (MDR) Acinetobacter baumannii bacteremia. DESIGN: A retrospective, matched-cohort study. SETTING: A tertiary care university teaching hospital. METHODS: A matched case-control (1 : 1) study was conducted to compare the differences in clinical and economic outcomes of patients with MDR A. baumannii bacteremia and patients with non-MDR A. baumannii bacteremia. Case patients were matched to control patients on the basis of sex, age, severity of underlying and acute illness, and length of hospital stay before onset of bacteremia. RESULTS: Forty-six (95.8%) of 48 cases with MDR A. baumannii bacteremia were eligible for the study and matched with appropriate controls. The sepsis-related mortality rate was 34.8% among cases and 13.0% among controls, for an attributable mortality rate of 21.8% (adjusted odds ratio, 4.1 [95% confidence interval, 1.1-15.7]; P=.036). After the onset of bacteremia, cases and controls had a significantly different length of hospital stay (54.2 vs 34.1 days; P=.006), hospitalization cost (US$9,349 vs US$4,865; P=.001), and antibiotic therapy cost (US$2,257 vs US$1,610; P=.014). Thus, bacteremia due to MDR A. baumannii resulted in 13.4 days of additional hospitalization and US$3,758 of additional costs, compared with bacteremia due to non-MDR A. baumannii. CONCLUSIONS: Patients with MDR A. baumannii bacteremia had a higher mortality rate and incurred greater medical costs than patients with non-MDR A. baumannii bacteremia.

    Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Publishing Authors By Initials

    ny leeNY Lee,hc leeHC Lee,ny koNY Ko,cm changCM Chang,hi shihHI Shih,cj wuCJ Wu,wc koWC Ko,ny leeNY Lee,hc leeHC Lee,ny koNY Ko,cm changCM Chang,hi shihHI Shih,cj wuCJ Wu,wc koWC Ko,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Infection control and hospital epidemiology : the

    VOLUME: 28

    Page Numbers: 713-9

    Journal Abbreviation:

    ISSN: 0899-823X

    DAY: 14

    MONTH: 05

    YEAR: 2007

    Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8804099

    Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.

    AFFILIATION: Department of Internal Medicine, Division of Infectious Diseases, National Cheng Kung University Hospital, Tainan, Taiwan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Infect Control Hosp Epidemiol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News